Dan M. Casalaz

163 Studley Road
Melbourne, VIC 3084, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Changes in Atopic Sensitisation From 1 to 5 Years of Age: Longitudinal Data From the MIS BAIR Trial.

Changes in Atopic Sensitisation From 1 to 5 Years of Age: Longitudinal Data From the MIS BAIR Trial.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: July 09, 2025

Neonatal Bacillus Calmette-Guérin Vaccination Decreases Eczema Incidence at 5 years: The MIS BAIR Randomised Controlled Trial.

Neonatal Bacillus Calmette-Guérin Vaccination Decreases Eczema Incidence at 5 years: The MIS BAIR Randomised Controlled Trial.

Journal: Allergy
Published: May 30, 2025

Neonatal BCG vaccination to prevent respiratory infections in the first 5 years of life: results from the MIS BAIR randomised controlled trial.

Neonatal BCG vaccination to prevent respiratory infections in the first 5 years of life: results from the MIS BAIR randomised controlled trial.

Journal: Vaccine
Published: May 21, 2025

Neonatal BCG vaccination to prevent asthma: Results from the MIS BAIR randomized controlled trial.

Neonatal BCG vaccination to prevent asthma: Results from the MIS BAIR randomized controlled trial.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: February 25, 2025

Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled Trial.

Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled Trial.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: March 26, 2024

Discordance Between Diagnosis Tools for Assessing Eczema in Infants: A Challenge for Intervention Trials.

Discordance Between Diagnosis Tools for Assessing Eczema in Infants: A Challenge for Intervention Trials.

Journal: Dermatitis : contact, atopic, occupational, drug
Published: February 16, 2022

Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial.

Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial.

Journal: American journal of respiratory and critical care medicine
Published: January 10, 2022

Feasibility and acceptability of targeted salivary cytomegalovirus screening through universal newborn hearing screening.

Feasibility and acceptability of targeted salivary cytomegalovirus screening through universal newborn hearing screening.

Journal: Journal of paediatrics and child health
Published: May 24, 2021

Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trial.

Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trial.

Journal: Allergy
Published: April 16, 2021

Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled Trial.

Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled Trial.

Journal: The Journal of infectious diseases
Published: March 19, 2021

Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guérin (BCG) vaccine.

Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guérin (BCG) vaccine.

Journal: Vaccine
Published: April 10, 2020

Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting.

Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting.

Journal: BMJ open
Published: December 18, 2019
Showing 1-12 of 23

Last Updated: 09/26/2026